SynaptixBio collaborates with Evotec to boost search for rare disease therapies EP News Bureau Jul 23, 2024 SynaptixBio and Evotec are working to develop new candidate therapies for a specific leukodystrophy
New approvals to revolutionise myelofibrosis treatment landscape across 8MM: GlobalData EP News Bureau Jun 5, 2023 The MF market will grow from $2.39 billion in 2021 to $2.89 billion in 2031 across the 8MM, registering a compound annual growth…
